Skip to main navigation
  • About Us
    • Who We Are
    • Management Team
    • Founders
    • Board of Directors
    • Core Values
    • In The News
  • Our Approach
    & Programs
    • Gene Therapy
    • Pipeline
    • Our Programs
    • Manufacturing
    • Publications
  • Patients
    & Caregivers
    • About Gene Therapy
    • Parkinson’s Disease FAQ
    • Our Clinical Trials
    • Patient Resources
  • For Investors
    & Media
    • Investor Overview
    • Stock Information
      • Stock Quote
      • Stock Chart
    • Press Releases
    • Events and Presentations
      • Event Calendar
      • Past Events
      • Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Documents & Charters
      • Contact the Board
    • Financial Information
      • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Investor FAQs
    • Contact Us
  • Join
    Our Team
    • Who We Are
    • Benefits
    • Join Us
    • Awards
  • Contact
  • About Us
    • Who We Are
    • Management Team
    • Founders
    • Board of Directors
    • Core Values
    • In The News
  • Our Approach
    & Programs
    • Gene Therapy
    • Pipeline
    • Our Programs
    • Manufacturing
    • Publications
  • Patients
    & Caregivers
    • About Gene Therapy
    • Parkinson’s Disease FAQ
    • Our Clinical Trials
    • Patient Resources
  • For Investors
    & Media
    • Investor Overview
    • Stock Information
      • Stock Quote
      • Stock Chart
    • Press Releases
    • Events and Presentations
      • Event Calendar
      • Past Events
      • Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Documents & Charters
      • Contact the Board
    • Financial Information
      • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Investor FAQs
    • Contact Us
  • Join
    Our Team
    • Who We Are
    • Benefits
    • Join Us
    • Awards
  • Contact

Investors & Media

  • Investor Overview
  • Stock Information
    • Stock Quote
    • Stock Chart
  • Press Releases
  • Events and Presentations
    • Event Calendar
    • Past Events
    • Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Documents & Charters
    • Contact the Board
  • Financial Information
    • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Investor FAQs
  • Contact Us

SEC Filings

Document Details

Form
10-K
Filing Date
Feb 25, 2021
Document Date
Dec 31, 2020
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Voyager Therapeutics Inc.
Issuer
Voyager Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - EX-101.CAL
EX-101.DEF - EX-101.DEF
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT
  • Print Page
  • RSS Feeds
  • Share Page
    X
    • Share on:
    • Facebook
    • Twitter
    • LinkedIn
    • Google+
    • Reddit
    • Digg
    • Google
    • Delicious
    • StumbleUpon
    •  
       
  • E-mail Alerts
  • IR Contacts

Data provided by Nasdaq. Minimum 15 minutes delayed.

  • About Us
  • Our Approach
    & Programs
  • Patients
    & Caregivers
  • For Investors
    & Media
  • Join Our
    Team
  • Contact

© Voyager Therapeutics All rights served.

  • LinkedIn
  • Terms of Use
  • Sitemap